Mach7 Technologies Ltd. decided to sell its 3D medical business, citing a competitive environment and less-than-expected synergies.
The divestiture will enable Mach7 Technologies to focus on its enterprise imaging business. Further, the divestment and other initiatives will allow the company to book annual cost savings of at least A$1.2 million.
Separately, the company appointed Mike Lampron COO. Lampron was most recently vice president, services, at iCAD Inc.